Evaluation of Report-Back Strategies for Long-term and Short-term Exposure Information in Rural Tribal Populations

December 8, 2025 updated by: Darrah Sleeth, University of Utah

The goal of this study is to evaluate different ways to provide feedback about environmental sampling results to participants. Specifically, the study will look at exposures with long-term risk (radon) and short-term risk (indoor particulate matter, PM2.5). The hypothesis is that providing feedback in real-time will result in participants engaging in more activities to try to reduce their exposure. One of the main questions of interest is: How does the information messenger impact the effectiveness of report-back strategies in rural, tribal populations?

Participants will have radon and PM2.5 measurement equipment installed at their home and will answer questions about any actions they took to reduce exposure. Previously developed approaches to reporting back those exposures will be used to test which feedback method results in more actions to reduce exposure.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

112

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Enrolled member of the participating tribe

Exclusion Criteria:

  • Participant in one of our previous studies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Real-Time Exposure Data
Participants in this arm will get their data reported-back in real-time. There will be a total of 4 different strategies tested based on a combination of two (2) messengers and two (2) formats tested.
The first type of messenger (specific details TBD) that will be used to deliver the environmental sampling results.
The second type of messenger (specific details TBD) that will be used to deliver the environmental sampling results.
The first type of format (specific details TBD) that will be used to deliver the environmental sampling results.
The second type of format (specific details TBD) that will be used to deliver the environmental sampling results.
Experimental: Delayed Exposure Data
Participants in this arm will get their data reported-back only after all exposure data are collected (i.e., delayed approximately 2 months). There will be a total of 4 different strategies tested based on a combination of two (2) messengers and two (2) formats tested.
The first type of messenger (specific details TBD) that will be used to deliver the environmental sampling results.
The second type of messenger (specific details TBD) that will be used to deliver the environmental sampling results.
The first type of format (specific details TBD) that will be used to deliver the environmental sampling results.
The second type of format (specific details TBD) that will be used to deliver the environmental sampling results.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exposure Reduction Behaviors
Time Frame: 3 months after report-back
This will be collected using a questionnaire with a likert scale from 1 (not at all) to 10 (a lot) of how often certain exposure-reduction behaviors are performed.
3 months after report-back
Exposure Reduction Behaviors
Time Frame: 6 months after report-back
This will be collected using a questionnaire with a likert scale from 1 (not at all) to 10 (a lot) of how often certain exposure-reduction behaviors are performed.
6 months after report-back
Exposure Reduction Behaviors
Time Frame: 12 months after report-back
This will be collected using a questionnaire with a likert scale from 1 (not at all) to 10 (a lot) of how often certain exposure-reduction behaviors are performed.
12 months after report-back

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

April 1, 2028

Study Registration Dates

First Submitted

September 9, 2024

First Submitted That Met QC Criteria

September 9, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

December 12, 2025

Last Update Submitted That Met QC Criteria

December 8, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • R01ES036260 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Behavior Change

Clinical Trials on Messenger 1

Subscribe